AdaptHealth vs Bruker
Bruker reported revenue of $3.4 billion in fiscal 2025, about the same as AdaptHealth's $3.2 billion in fiscal 2025. AdaptHealth's revenue fell 0.5% in its latest year, and Bruker's grew 2.1%. AdaptHealth had an operating margin of 2.8%, against 2.0% at Bruker. Free cash flow was $219 million at AdaptHealth and $43 million at Bruker.
Side by side
| AdaptHealth | Bruker | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $3.2B | $3.4B |
| Revenue growth | −0.5% | 2.1% |
| Revenue growth a year, last 5 years | 25.2% | 11.6% |
| Gross margin | 18.8% | 45.9% |
| Operating margin | 2.8% | 2.0% |
| Net margin | −2.2% | −0.2% |
| Free cash flow | $219M | $43M |
| Free cash flow margin | 6.8% | 1.3% |
| Return on capital | 2.1% | 0.9% |
| Net debt to EBITDA | 3.5x | 5.5x |
| Dividends and buybacks | $0M | $33M |
| Change in diluted share count | −0.3% | 1.5% |
| Last close | $5.93 | $58.23 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $24.9 million, sold $278,287 | sold $3.6 million |
| Piotroski F-score | 4 of 9 | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AdaptHealthBruker
Operating margin
Percent of revenue
AdaptHealthBruker
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AdaptHealthBruker
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AdaptHealth and Bruker pages.